MedTrace Logo

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

NCT00163631 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2006-10-04

No results posted yet for this study

Summary

Investigate vasoactive medicators in portal hypertension on stored sera

Conditions

  • Portal Hypertension

Sponsors & Collaborators

  • Bayside Health

    lead OTHER_GOV

Principal Investigators

  • William W Kemp, MBBS FRACP · The Alfred

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00163631 on ClinicalTrials.gov